| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $70.4M | +168.0% |
| SG&A Expense | $14.3M | +173.4% |
| Operating Income | -$84.7M | -168.9% |
| Net Income | -$71.9M | -141.3% |
| EPS (Basic) | -$1.99 | +65.5% |
| EPS (Diluted) | -$1.99 | +65.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.3M | -43.8% |
| Current Assets | $249.1M | +120.8% |
| Total Assets | $251.6M | +119.9% |
| Current Liabilities | $10.5M | +29.9% |
| Stockholders' Equity | $241.2M | +561.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.2M | -177.8% |
| Investing Cash Flow | -$160.5M | -637.5% |
| Financing Cash Flow | $203.2M | +58.8% |